ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Challoner: We Recommended FDA Replace 510(k) Clearance

July 4, 2014

In Brief: Capp Heads Roentgen Ray Society; Annual Lecture, Chair Honors Charles Spurr

June 22, 1990

DCPC Board Approves Nine Concepts, New Small Cancer Control Grants, Rerelease Of FDA For Nutrition Core Grants

January 20, 1984

Waxman To Introduce Reauthorization Bill Next Month, Intends To Complete Action By Session End

July 22, 1988

In Brief: Friedman Leads FDA During Search; Mead Retires From NCI; Freireich Honored

March 14, 1997

Comments Invited On Centers Program

November 27, 1987